pplication. [0039] U.S. Pat. No. 5,299,569 (Wernicke et al.) is directed to the use of implantable pulse generator technology for treating and controlling neuropsychiatric disorders including schizophrenia, depression, and borderline personality disorder. [0040] U.S. Pat. No. 6,205,359 B1 (Boveja) is directed to adjunct therapy of partial complex epilepsy and generalized epilepsy using an implante